Episode 8 - The Global Practice of Pathology

Dan Milner, MD, MSc (Epi), MBA, FASCP, Chief Medical Officer, ASCP

Dr. Milner completed his MD at the University of Alabama School of Medicine in 2000 and his residency/fellowship in Anatomic Pathology/Clinical Pathology/Microbiology at the Brigham and Women’s Hospital in 2005. His masters of science in epidemiology is from the Harvard T. H. Chan School of Public Health were he remains an adjunct professor. He completed his masters in business administration from the UAB Collat School of Business. Dr. Milner began working in Africa in 1997 as a medical student and has built an international reputation as an expert in cerebral malaria. In parallel with this, he has been heavily involved in pathology capacity building in many countries and, most notably, led the team that built an anatomic pathology laboratory in Rwanda and Haiti for advance cancer diagnostics. Before joining ASCP in 2016, Dr. Milner spent 11 years at the Brigham and Women’s Hospital/Harvard Medical School where he taught pathology, microbiology, and infectious disease; was the primary lead for infectious disease consultations in AP/CP; and was the recipient of numerous research grants in the areas of malaria and HIV. Dr. Milner is the author of over 150 publications and has presented national and internationally on his work in more than 25 countries. At ASCP, Dr. Milner is responsible for medical oversight of all organizational activities. He provides vision, direction, and execution of ASCP’s Center for Global Health programs including communicable and non-communicable diseases. Dr. Milner and the CGH manage over 80 active collaborations with governments, NGOs, industry, academic centers, and international organizations with activity in more than 30 countries. Dr. Milner’s leadership roles/experience with global efforts is extensive and he serves as a direct collaborative consultant in the area of diagnostic pathology for global health to Partners in Health, Mount Sinai, Memorial Sloan Kettering, Clinton Health Access Initiative, American Cancer Society, BIO Ventures for Global Health, Bristol-Myers Squibb, World Health Organization, World Economic Forum, World Child Cancer, Perkin-Elmer, International Collaboration for Cancer Reporting, International Cancer Control Partnership, City Cancer Challenge, and the Union for International Cancer Control.